In summary, we demonstrated that AMP-IBP5 enhanced TJ barrier function in human keratinocytes and ameliorated dermatitis symptoms and restored skin barrier function in a mouse model of AD through LRP1. This evidence concerns the gene LRP1 and Alzheimer disease.